Page 22 - IMCJ April 2020

in the majority of large coenzyme Q clinical trials around 6. Littarru GP and Tiano L. Coenzyme Q10: Recent Developments. Molecular
Biotechnology. 2007;37:31-37.
10
the world over the past thirty years. 7. Kagan VE, et al. Role of Coenzyme Q and Superoxide in Vitamin E recycling.
The slide/image above shows how Pharma Nord’s Subcell Biochem. 1998;30:491-507.
patented process keeps their coenzyme Q in solution, 8. Albano CB, et al Distribution of Coenzyem Q Homologues in Brain.
Neurochem Res. May 2002;27(5):359-68.
10
which results in a product that is largely crystal free. 9. Gao S and Liu J. Association between circulating oxidized low-density
Coenzyme Q is an incredibly important nutrient, but in lipoprotein and atherosclerotic cardiovascular disease. Chronic Dis Transl
Med. 2017 Jun 25;3(2):89-94.
10
order to be effective, it must be well absorbed and 10. Mortensen SA. Dose-related decrease of serum coenzyme Q10 during
bioavailable. That’s why I use and recommend Pharma treatment with HMG-CoA reductase inhibitors. Mol Aspects Med. 1997;18
Suppl:S137-44.
Nord’s Bio-Quinone Active CoQ GOLD. 11. Sharma A, et al. Coenzyme Q10 and Heart Failure: A State-of-the-Art Review.
10
Circ Heart Fail. 9(4):e002639.
12. Mortensen SA, et al. The effect of coenzyme Q10 on morbidity and mortality
To Order: Practitioners, if you would like to get product in chronic heart failure: results from Q-SYMBIO: a randomized double-blind
trial. JACC. Heart Failure. 2014, 2(6): 641-649.
information or order Pharma Nord’s Bio-Quinone for 13. Mortensen SA, et al. Effect of Coenzyme Q10 in Europeans with chronic heart
yourself or for your patients, send a request to: failure: A sub-group analysis of the Q-Symbio randomized double-blind
practitioner@pharmanord.com study. Cardiology Journal. 2019, 26(2): 147-156.
14. Slehagen U, et al. Cardiovascular mortality and N-terminal-proBNP reduced
after combined selenium and coenzyme Q10 supplementation: a 5-year
References prospective randomized double-blind, placebo-controlled trial among elderly
1. Folkers K, Littarru GP, Ho L, Runge TM, Havanonda S, & Cooley D. (1970). Swedish citizens. International Journal of Cardiology. 2013, 167(5): 1860-1866.
Evidence for a deficiency of coenzyme Q10 in human heart disease. 15. Langsjoen P, et al. Treatment of Essential Hypertension With Coenzyme Q10.
International Journal of Vitamin Research 40(3):380-90. Mol Aspects Med. 1994;15 Suppl: S265-72.
2. NobelPrize.org. 2020. The Nobel Prize In Chemistry 1978. [online] Available 16. Folkers K, et al. Activities of vitamin Q10 in animal models and a serious
at: https://www.nobelprize.org/prizes/chemistry/1978/summary/ Accessed 23 deficiency in patients with cancer. Biochem Biophys Res Commun 234:296-
March 2020]. 299, 1997.
3. Pelton R. The Drug-Induced Nutrient Depletion Handbook (2nd Edition). 17. Seyfried T. Cancer as a Metabolic Disease: On the Origin, Management and
Hudson, OH, Lexi-Comp, 2001. Prevention of Cancer. Hoboken, NJ. John Wyley & Sons, Inc. 2012.
4. De Barcelos IP and Haas RH. CoQ10 and Aging. Biology (Basel). 2019 18. Ernster L and Dallner G. Biochemical, physiological and medical aspects of
Jun;8(2):28. ubiquinone function. Biochim Biophys Acta. May 24, 1995;1271(1):195-204.
5. Ernster L and Forsmakr-Andree P. Ubiquinol: An Endogenous Antioxidant in 19. Lockwood K, et al. Partial and complete regression of breast cancer in patients
Aerobic Organisms. Clin Investig. 1973;71(8 Suppl):S60-65. in relation to dosage of coenzyme Q10. Biochem Biophys Res Commun. 1994
Mar 30;199(3):1504-8.
20 Integrative Medicine • Vol. 19, No. 2 • April 2020 Pelton—Coenzyme Q 10